Lv4
408 积分 2025-02-14 加入
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1天前
待确认
mRNA-based cancer therapeutics
1天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
4天前
已完结
A coronary artery disease-associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell–cell junctions
4天前
已完结
Efficient chemical reprogramming of human T cells to pluripotent stem cells
6天前
已完结
Chemical reprogramming of human blood cells to pluripotent stem cells
6天前
已完结
Individualized mRNA cancer vaccines make strides
12天前
已完结
mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives
12天前
已完结
Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics
13天前
已关闭
Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives
1个月前
已完结
皖公网安备34019202002308
